Back
Cardiff Oncology Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
61
CRDF
Cardiff Oncology
Last Price:
$4.46
Seasonality Move:
13.5%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRDF is experiencing slight selling pressure.
Cardiff Oncology Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.17 | Buy |
20-day SMA: | 3.64 | Buy |
50-day SMA: | 3.4 | Buy |
200-day SMA: | 3.38 | Buy |
8-day EMA: | 4.15 | Buy |
20-day EMA: | 3.85 | Buy |
50-day EMA: | 3.41 | Buy |
200-day EMA: | 1.85 | Buy |
Cardiff Oncology Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.27 | Buy |
Relative Strength Index (14 RSI): | 72.56 | Buy |
Chaikin Money Flow: | -345883 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.24 - 4.1) | Buy |
Bollinger Bands (100): | (2.81 - 3.97) | Buy |
Cardiff Oncology Technical Analysis
Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Cardiff Oncology Stock
Is Cardiff Oncology Stock a Buy?
-
Cardiff Oncology share price is 4.45 while CRDF 8-day simple moving average is 4.17, which is a Buy signal.
-
The stock price of CRDF is 4.45 while Cardiff Oncology 20-day SMA is 3.64, which makes it a Buy.
-
Cardiff Oncology 50-day simple moving average is 3.40 while CRDF share price is 4.45, making it a Buy technically.
-
CRDF stock price is 4.45 and Cardiff Oncology 200-day simple moving average is 3.38, creating a Buy signal.
CRDF Technical Analysis vs Fundamental Analysis
Buy
61
Cardiff Oncology (CRDF)
is a Buy
Is Cardiff Oncology a Buy or a Sell?
-
Cardiff Oncology stock is rated a BuyThe current Cardiff Oncology [CRDF] share price is $4.45. The Score for CRDF is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
Cardiff Oncology Stock Info
Market Cap:
296M
Price in USD:
4.45
Share Volume:
1.4M
Cardiff Oncology 52-Week Range
52-Week High:
5.64
52-Week Low:
2.01
Buy
61
Cardiff Oncology (CRDF)
is a Buy
Cardiff Oncology Share Price Forecast
-
What is the Cardiff Oncology stock price today?The Cardiff Oncology stock price is 4.45 USD today.
-
Will CRDF stock go up or go down?Cardiff Oncology> share price is forecast to RISE/FALL based on technical indicators
-
Is Cardiff Oncology overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cardiff Oncology is not overvalued.
Is Cardiff Oncology Stock a Buy?
-
Cardiff Oncology share price is 4.45 while CRDF 8-day exponential moving average is 4.15, which is a Buy signal.
-
The stock price of CRDF is 4.45 while Cardiff Oncology 20-day EMA is 3.85, which makes it a Buy.
-
Cardiff Oncology 50-day exponential moving average is 3.41 while CRDF share price is 4.45, making it a Buy technically.
-
CRDF stock price is 4.45 and Cardiff Oncology 200-day simple moving average is 1.85, creating a Buy signal.
Fundamental Analysis of Cardiff Oncology
Is Cardiff Oncology a good investment?
-
Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.03 per share, an increase this year of $0.17 per share, and a decrease next year of $0.12 per share.
Technical Analysis of Cardiff Oncology
Should I short Cardiff Oncology stock?
-
CRDF Moving Average Covergence Divergence (MACD) indicator is 0.27, suggesting Cardiff Oncology is a Buy
-
Cardiff Oncology Relative Strength Index (RSI) is 72.56, which suggest Cardiff Oncology is overbought
-
The Bollinger Bands (25) for Cardiff Oncology is (3.24 - 4.1), which suggest Cardiff Oncology is a Buy
-
The Bollinger Bands (100) for Cardiff Oncology is (2.81 - 3.97), which suggest Cardiff Oncology is a Buy
* Cardiff Oncology stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.